Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Mortality in adults with sickle cell disease and pulmonary hypertension.

Mehari A, Gladwin MT, Tian X, Machado RF, Kato GJ.

JAMA. 2012 Mar 28;307(12):1254-6. doi: 10.1001/jama.2012.358. No abstract available.

2.

N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ, Taveira-DaSilva AM, Ballas SK, Blackwelder W, Xu X, Hunter L, Barton B, Waclawiw M, Castro O, Gladwin MT; MSH Investigators..

JAMA. 2006 Jul 19;296(3):310-8.

PMID:
16849664
3.

Hemodynamic predictors of mortality in adults with sickle cell disease.

Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G, Xu D, Seamon C, Adams-Graves P, Castro OL, Minniti CP, Sachdev V, Taylor JG 6th, Kato GJ, Machado RF.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):840-7. doi: 10.1164/rccm.201207-1222OC.

4.

Pulmonary hypertension in sickle cell disease.

Sutton LL, Castro O, Cross DJ, Spencer JE, Lewis JF.

Am J Cardiol. 1994 Sep 15;74(6):626-8. No abstract available.

PMID:
8074054
5.

Pulmonary hypertension in sickle cell disease: diagnosis and management.

Ataga KI, Klings ES.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):425-31. doi: 10.1182/asheducation-2014.1.425. Review.

PMID:
25696889
6.

Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different.

Simonneau G, Parent F.

Eur Respir J. 2012 Jan;39(1):3-4. doi: 10.1183/09031936.00119811. No abstract available.

7.

Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease.

Fonseca GH, Souza R, Salemi VM, Jardim CV, Gualandro SF.

Eur Respir J. 2012 Jan;39(1):112-8. doi: 10.1183/09031936.00134410.

8.

Pulmonary hypertension and NO in sickle cell.

Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ, Kim-Shapiro DB, Machado R, Morris CR, Steinberg MH, Vichinsky EP.

Blood. 2010 Aug 5;116(5):852-4. doi: 10.1182/blood-2010-04-282095. No abstract available.

9.

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease..

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.

10.

Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years.

Lee MT, Small T, Khan MA, Rosenzweig EB, Barst RJ, Brittenham GM.

Br J Haematol. 2009 Aug;146(4):437-41. doi: 10.1111/j.1365-2141.2009.07779.x.

11.

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension.

Machado RF, Martyr S, Kato GJ, Barst RJ, Anthi A, Robinson MR, Hunter L, Coles W, Nichols J, Hunter C, Sachdev V, Castro O, Gladwin MT.

Br J Haematol. 2005 Aug;130(3):445-53.

12.

Clinical differences between children and adults with pulmonary hypertension and sickle cell disease.

Hagar RW, Michlitsch JG, Gardner J, Vichinsky EP, Morris CR.

Br J Haematol. 2008 Jan;140(1):104-12.

PMID:
17916102
13.

Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease.

Sharma S, Efird J, Kadali R, Mehra S, Chohan H, Daggubati R, Liles D, Gouge C, Boettger P, Knupp C.

Clin Cardiol. 2013 Sep;36(9):524-30. doi: 10.1002/clc.22153.

14.

Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.

Sachdev V, Kato GJ, Gibbs JS, Barst RJ, Machado RF, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli EM, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Hannoush H, Goldsmith JC, Gladwin MT, Gordeuk VR; Walk-PHASST Investigators..

Circulation. 2011 Sep 27;124(13):1452-60. doi: 10.1161/CIRCULATIONAHA.111.032920.

15.
16.

Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.

Lin EE, Rodgers GP, Gladwin MT.

Curr Hematol Rep. 2005 Mar;4(2):117-25. Review.

PMID:
15720960
17.

Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.

Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, Godeau B, Galacteros F, Brun-Buisson C, Brochard L, Maitre B.

Am J Respir Crit Care Med. 2008 Mar 15;177(6):646-53. doi: 10.1164/rccm.200710-1606OC.

PMID:
18174543
18.

Pulmonary hypertension in an adult sickle cell population in Guadeloupe.

Billy-Brissac R, Blanchet-Deverly A, Etienne-Julan M, Foucan L.

Int J Cardiol. 2009 Jun 12;135(1):122-3. doi: 10.1016/j.ijcard.2008.01.015.

PMID:
18466988
19.

A hemodynamic study of pulmonary hypertension in sickle cell disease.

Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.

N Engl J Med. 2011 Jul 7;365(1):44-53. doi: 10.1056/NEJMoa1005565.

20.
Items per page

Supplemental Content

Support Center